Unique ID issued by UMIN | UMIN000018998 |
---|---|
Receipt number | R000021974 |
Scientific Title | Evaluation of perioperative changes of blood coagulation factors in patients with left ventricular assist device implantation and impact of XIII factors in postoperative hemostasis after LVAD implantation |
Date of disclosure of the study information | 2015/10/01 |
Last modified on | 2020/08/17 15:21:28 |
Evaluation of perioperative changes of blood coagulation factors in patients with left ventricular assist device implantation and impact of XIII factors in postoperative hemostasis after LVAD implantation
Evaluation of perioperative changes of blood coagulation factors in patients with left ventricular assist device implantation and impact of XIII factors in postoperative hemostasis after LVAD implantation
Evaluation of perioperative changes of blood coagulation factors in patients with left ventricular assist device implantation and impact of XIII factors in postoperative hemostasis after LVAD implantation
Evaluation of perioperative changes of blood coagulation factors in patients with left ventricular assist device implantation and impact of XIII factors in postoperative hemostasis after LVAD implantation
Japan |
patients with end-stage heart failure who underwent left ventricular assist device support
Cardiovascular surgery | Blood transfusion |
Others
NO
The aim of this study is to evaluate the changes of blood coagulation factors in postoperative periods and the efficacy of concentrates of XIII factor in prevention of postoperative bleeding event
Efficacy
Confirmatory
Pragmatic
Phase IV
bleeding complication in postoperative periods including brain hemorrage, gastrointestinal hemorrage and wound bleeding requring blood transfusion
blood transfusion volume in postoperative period
amount of bleeding in postoperative period
perioperative changes of blood coagulation factors
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
NO
NO
Institution is not considered as adjustment factor.
YES
Numbered container method
2
Treatment
Medicine |
control group:LVAD implantation
treatment group: LVAD implantation with postoperative administraion of concentrates of blood coagulation factor XIII (Fibrogammin® P 240U/V 5V) at the time of admission of intensive care unit and 24 and 48 hours after operation
20 | years-old | <= |
65 | years-old | >= |
Male and Female
the patients with end-stage heart failure due to dilated cardiomyopathy, ischemic cardiomyopathy and other cardiomyopathy who is planned to undergo left ventricular assit device implantation
the patients with sensitivity to concentrate of blood coagulaton factor XIII
the patients with sensitivity to other blood products
60
1st name | |
Middle name | |
Last name | Yoshiki Sawa |
Graduate school of Medicine, Osaka University
Department of Cardiovascular Surgery
2-2 Yamadaoka, Suita City, Osaka
06-6879-3154
k-domae@surg1.med.osaka-u.ac.jp
1st name | |
Middle name | |
Last name | Keitaro Domae |
Graduate school of Medicine, Osaka University
Department of Cardiovascular Surgery
2-2 Yamadaoka, Suita City, Osaka
06-6879-3154
k-domae@surg1.med.osaka-u.ac.jp
Department of Crdiovascular Surgery, Graduate School of Medicine, Osaka University
none
Other
none
NO
大阪大学附属病院(大阪府)
2015 | Year | 10 | Month | 01 | Day |
Unpublished
Terminated
2015 | Year | 09 | Month | 11 | Day |
2015 | Year | 10 | Month | 15 | Day |
2015 | Year | 10 | Month | 01 | Day |
2020 | Year | 03 | Month | 31 | Day |
2015 | Year | 09 | Month | 13 | Day |
2020 | Year | 08 | Month | 17 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000021974